2024 ASCO® Annual Meeting Insights Hub

Meeting coverage & Vumedi’s exclusive highlights, all in one place.

 

ASCO® 2024 Insights: "Multi-Center Phase II Trial Investigating Safety & Efficacy of Osimertinib + Consolidative SABR in Advanced EGFRm NSCLC"

37 views
June 10, 2024
0 Comments
Login to view comments. Click here to Login
Lung